The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity.
Helsen CW, Hammill JA, Lau VWC, Mwawasi KA, Afsahi A, Bezverbnaya K, Newhook L, Hayes DL, Aarts C, Bojovic B, Denisova GF, Kwiecien JM, Brain I, Derocher H, Milne K, Nelson BH, Bramson JL.
Helsen CW, et al. Among authors: bramson jl.
Nat Commun. 2018 Aug 3;9(1):3049. doi: 10.1038/s41467-018-05395-y.
Nat Commun. 2018.
PMID: 30076299
Free PMC article.